Seiji Ohashi

728 total citations
7 papers, 615 citations indexed

About

Seiji Ohashi is a scholar working on Nephrology, Clinical Biochemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Seiji Ohashi has authored 7 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Nephrology, 4 papers in Clinical Biochemistry and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Seiji Ohashi's work include Advanced Glycation End Products research (4 papers), Diabetes and associated disorders (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Seiji Ohashi is often cited by papers focused on Advanced Glycation End Products research (4 papers), Diabetes and associated disorders (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Seiji Ohashi collaborates with scholars based in Japan and United States. Seiji Ohashi's co-authors include Toshio Doi, Masayoshi Takeuchi, Yasuhiko Yamamoto, Hiroshi Yamamoto, Takuo Watanabe, Shin Takasawa, Shigeru Sakurai, Hideto Yonekura, Hiroshi Okamoto and Ichiro Kato and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and American Journal Of Pathology.

In The Last Decade

Seiji Ohashi

5 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seiji Ohashi Japan 4 352 236 203 129 121 7 615
K. F. Hanssen Norway 14 273 0.8× 286 1.2× 424 2.1× 70 0.5× 104 0.9× 24 862
Richard Bucala United States 5 390 1.1× 72 0.3× 217 1.1× 81 0.6× 59 0.5× 9 535
Clotilde Zoukourian France 4 525 1.5× 71 0.3× 293 1.4× 75 0.6× 124 1.0× 5 764
Harshini Mudaliar Australia 8 119 0.3× 185 0.8× 286 1.4× 73 0.6× 209 1.7× 9 671
Dmitri Belov United States 5 667 1.9× 77 0.3× 253 1.2× 80 0.6× 280 2.3× 8 903
Luis Concepcion United States 8 88 0.3× 167 0.7× 157 0.8× 33 0.3× 222 1.8× 13 490
Maria Arriero Spain 11 366 1.0× 46 0.2× 134 0.7× 48 0.4× 230 1.9× 15 682
Aowen Zhuang Australia 9 92 0.3× 91 0.4× 149 0.7× 32 0.2× 114 0.9× 18 383
Can Wu China 13 66 0.2× 172 0.7× 89 0.4× 45 0.3× 333 2.8× 15 710
Motofumi Sasaki Japan 13 104 0.3× 177 0.8× 334 1.6× 29 0.2× 202 1.7× 16 781

Countries citing papers authored by Seiji Ohashi

Since Specialization
Citations

This map shows the geographic impact of Seiji Ohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiji Ohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiji Ohashi more than expected).

Fields of papers citing papers by Seiji Ohashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiji Ohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiji Ohashi. The network helps show where Seiji Ohashi may publish in the future.

Co-authorship network of co-authors of Seiji Ohashi

This figure shows the co-authorship network connecting the top 25 collaborators of Seiji Ohashi. A scholar is included among the top collaborators of Seiji Ohashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seiji Ohashi. Seiji Ohashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Ohashi, Seiji, et al.. (2016). Cholesterin Granuloma of the Pancreas. The Japanese Journal of Gastroenterological Surgery. 49(5). 426–432.
2.
Inoue, Toru, Katsuyuki Nagatoya, Nobuhisa Shibahara, et al.. (2007). Influence of Sevelamer on Mineral Metabolism and Hyperparathyroidism in Japanese Hemodialysis Patients. Therapeutic Apheresis and Dialysis. 11(3). 210–214. 1 indexed citations
3.
Ohashi, Seiji, Hideharu Abe, Toshikazu Takahashi, et al.. (2004). Advanced Glycation End Products Increase Collagen-specific Chaperone Protein in Mouse Diabetic Nephropathy. Journal of Biological Chemistry. 279(19). 19816–19823. 47 indexed citations
4.
Yamamoto, Yasuhiko, Ichiro Kato, Toshio Doi, et al.. (2002). The role of AGE–RAGE system in the development of diabetic nephropathy in vivo. International Congress Series. 1245. 45–50. 3 indexed citations
5.
Yamamoto, Yasuhiko, Ichiro Kato, Toshio Doi, et al.. (2001). Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. Journal of Clinical Investigation. 108(2). 261–268. 40 indexed citations
6.
Yamamoto, Yasuhiko, Ichiro Kato, Toshio Doi, et al.. (2001). Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. Journal of Clinical Investigation. 108(2). 261–268. 409 indexed citations
7.
Hirata, Michinori, Naoshi Fukushima, Kenichiro Kusano, et al.. (2001). A Vitamin D Analog Ameliorates Glomerular Injury on Rat Glomerulonephritis. American Journal Of Pathology. 158(5). 1733–1741. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026